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Abstract
Background: Rhabdomyolysis secondary to quinolones is not frequent. There are scarce reports in the literature
associating rhabdomyolysis to levofloxacin. We describe a case of levofloxacin-induced rhabdomyolysis.
Case presentation: A 52-year-old African-American man presented with muscle tightness after taking three doses
of levofloxacin. He had elevated creatine kinase without acute kidney injury. His symptoms resolved after
discontinuation of levofloxacin and supportive care.
Conclusions: It is fascinating that our patient has a prior history of rhabdomyolysis, likely from levofloxacin.
Our case highlights the need to be mindful of this potentially life-threatening complication of levofloxacin.
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Background
Levofloxacin is a deoxyribonucleic acid (DNA) gyrase
inhibitor that inhibits the relaxation of supercoiled DNA,
thus promoting DNA strand breakage. Well-known adverse
reactions of levofloxacin are gastrointestinal (nausea and
vomiting approximately 5 %), central nervous system (CNS;
seizure <1 %), cardiovascular (arrhythmia <1 %), and muscu-
loskeletal (tendinitis <1 %) [1]. We describe a less-known
side effect of levofloxacin, which is a commonly prescribed
antibiotic in the United States of America (USA) [2].
Case presentation
A 52-year-old African-American man with beta thalas-
semia, gout, and hypertension presented with the chief
complaint of tightness and fatigue in his thigh muscles
for 2 days that subsequently involved his shoulders and
arms causing difficulty with ambulation. He did not have
any prodromal or provoking events except that he took
three doses of levofloxacin 750 mg prescribed for a
lower respiratory tract infection prior to the onset of his
symptoms. By the third dose, along with the worsening
of symptoms he noticed discoloration of urine. He had a
history of rhabdomyolysis 4 years earlier thought to be
secondary to levofloxacin. His vital signs were normal
and a physical examination was significant for general-
ized muscle tenderness. His urine was dark brown and
turbid, and negative for glucose, bilirubin, ketones, leu-
koesterase, and nitrite but with 4+ blood and 0 to 2 red
blood cells per highpower field. Other laboratory results
during the current episode along with a comparison to
the prior episode are summarized in Table 1.
Levofloxacin was discontinued and aggressive intra-
venous hydration was started. His creatine kinase (CK)
gradually dropped over the next 10 days to <5000 U/L.
His serum creatinine remained <1 mg/dL. His aspartate
aminotransferase (AST) peaked at 1298 U/L while
alanine aminotransferase (ALT) remained around 300 U/L
and both tapered to a normal level. His clinical improve-
ment correlated with the drop in CK.
Discussion
Rhabdomyolysis is a severe form of necrotizing myop-
athy that occurs after acute muscle insult. Drug-induced
rhabdomyolysis is well documented and can occur via
primary or secondary myotoxic effect. Imbalance
between production and utilization of adenosine triphos-
phate (ATP) in the muscle caused by drugs can lead to
direct toxic effect on the sarcolemma. Secondary myo-
toxicity can occur via CNS depression causing prolonged
immobilization and pressure on large muscles [3]. Com-
mon causes of rhabdomyolysis such as trauma, exertion,
or seizure were absent in this case. Hypophosphatemia,
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hypokalemia, hypothyroidism, and infections (influenza,
mycoplasma) were excluded in our patient. His medica-
tions were reviewed and none of them were known to
have this adverse reaction [4]. The fact that he recovered
after discontinuation of the drug implies the contributory
role of levofloxacin.
The earliest report of quinolone-induced rhabdo-
myolysis was observed by Blain et al. in 1996 [1].
Levofloxacin-induced rhabdomyolysis was first reported
in 2000 and thus far only a few cases have been reported
[4–7]. Previous reports that rhabdomyolysis occurs
within 6 days of initiation of levofloxacin remained true
in our case also. The exact mechanism by which
levofloxacin induces rhabdomyolysis is not known yet.
A theory of vascular hyperpermeability is hypothesized.
Localized edema and mononuclear cells in muscles of
animal models after a systemic dose of fluoroquinolones
support this hypothesis. Tumor necrosis factor α
(TNFα), interleukin 1 (IL-1), histamine, and plasma
fibronectin are some of the mediators involved in this
vascular hyperpermeability [4]. Levofloxacin can also
lead to seizure activity and muscle breakdown by lower-
ing the seizure threshold; however, there was no seizure
activity in our patient.
Liver enzyme elevation, as seen in our patient, is com-
mon in rhabdomyolysis. ALT, a cytosolic enzyme is found
mostly in the liver. On the other hand, AST, which exists
in two isoforms (cytosolic and mitochondrial), is found in
the liver, heart, skeletal muscles, kidney, brain, and
pancreas. Elevated AST is seen in approximately 93 % of
cases and the normalization parallels the fall in CK levels
[8]. However, only 75 % of cases of rhabdomyolysis have
ALT elevations and its fall does not correlate with CK
level. Elevations of liver enzymes in rhabdomyolysis may
not be indicative of liver injury [8].
Diagnosis of rhabdomyolysis is by elevations in CK in
the blood. Although myoglobinuria can occur in 57 % of
patients, it often resolves before the rise in CK. Hence,
the absence of myoglobinuria does not rule out the diag-
nosis [3, 4]. Management is by stopping the offending
agent along with adequate hydration to prevent acute
renal failure. Systemic steroids although reported to have
a beneficial effect, were not used in this case due to lack
of scientific evidence [7].
Conclusions
Our case is fascinating given the prior history of rhabdo-
myolysis establishing a cause–effect relationship of
levofloxacin in the etiology of rhabdomyolysis. Thus it is
important to be aware and suspect this infrequent but
fatal side effect of this commonly prescribed antibiotic.
Table 1 Comparison of laboratory values during two episodes of rhabdomyolysis
Laboratory test 2015 2011 Normal range
White blood cell count 11.9 7.3 4.0–11.0 cells per μL
Hemoglobin 11.1 9.7 13.0–17.0 g/dL
Hematocrit 33.3 29.8 40.0–56.0 %
Mean corpuscular volume 60.6 66.6 80.0–100.0 fL
Red cell count 5.49 4.47 4.40-6.20 106/mm3
Red cell distribution width 22.5 23.3 11.0–16.0 %
Blood urea nitrogen 18 17 6–20 mg/dL
Serum creatinine 0.95 0.77 0.66–1.25 mg/dL
Serum sodium 136 138 136-145 mmol/L
Serum potassium 4.2 4.2 3.5-5.1 mmol/L
Serum phosphorus 3.6 3.3 2.7-4.5 mg/dL
Thyroid-stimulating hormone 3.4 2.72 0.465-4.68 μIU/mL
Aspartate aminotransferase (AST) 445 1137 17–59 U/L
Alanine aminotransferase (ALT) 133 314 21–72 U/L
Alkaline phosphatase (ALP) 50 78 56–119 U/L
Creatine kinase (CK) 92,950 268,666 55–170 U/L
Creatine kinase MB fraction 9.2 6.4 0.6–6.3 ng/mL
Lactate dehydrogenase 5542 21500 140–271 U/L
Mycoplasma pneumoniae antibody IGM Negative –
Influenza A and B rapid antigen Negative Negative
IgM, Immunoglobulin M; Cells per μL, cells per micro liter; g/dL, gram per deci liter; fL, femto liter; 106/mm3, 106 per cubic millimeter; mmol/L, millimol per liter;
μIU/mL, micro international units per milliliter; U/L, units per liter; ng/mL, nano gram per milliliter
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